The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Saavedra, Juan M ^a   Ito, Takeshi ^a   Nishimura, Yasuaki ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Angiotensin receptors; Brain injury; Cerebrovascular blood flow; Hypertension; Renin angiotensin system; Stroke

Indexed keywords

EID: 0001624239     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/14703203010020011801     Document Type: Review

References (68)

1. Phillis JW. The Regulation of Cerebral Blood Flow. Boca Raton, FL: CRC Press, 1993:1-425.
2. Mraovitch S, Sercombe R. Neurophysiological Basis of Cerebral Blood Flow Control-An Introduction. London: John Libbey, 1996:1-408.
3. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 1990;66:8-17.
4. Welch KMA, Caplan LR, Reis DJ, Siesjö, Weir D (eds) Primer on Cerebrovascular Diseases. New York: Academic Press, 1997:1-823.
5. Mayhan WG, Faraci FM, Baumbach GL, Heistad DD. Effects of aging on responses of cerebral arterioles. Am J Physiol 1990; 258;H1138-H1143.
6. Lartaud I, Makki T, Bray-des-Boscs L et al. Effect of chronic Ang 1-converting enzyme inhibition on aging processes. IV. Cerebral blood flow regulation. Am J Physiol 1994;267:R687-R694.
7. Squire IB. Actions of angiotensin II on CBF autoregulation in health and disease. J Hypertens 1994;12:1203-8.
8. Edvinsson L, MacKenzie E T, McCulloch J. (eds) Cerebral Blood Flow and Metab. New York: Raven Press, 1993:1-683.
9. Reis DJ, Iadecola C. Intrinsic central neural regulation of CBF and metabolism in relation to volume transmission. In: Fuxe K, and Agnati LF (eds) Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission. New York: Raven Press, 1991;523-38.
10. Page IH. Hypertension Mechanisms. New York: Grune & Startton, 1987:1-1002.
11. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 1992;13:329-80.
12. Saavedra JM. Emerging features of brain Angiotensin receptors. Reg Peptides 1999;85:31-45.
13. Timmermans PBMWM, Inagami T, Saavedra JM, Ardaillou R, Rosenfeld CR, Mendelsohn FAO. Angiotensin receptor subtypes and their pharmacology. In: Cuello AC, Collier B (eds) Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990's. Basel, Switzerland: Birkhguser Verlag, 1995:37-58.
14. Inagami T, Guo D-F, Kitami Y. Molecular biology of angiotensin II receptors: An overview. J Hypertens 1994;12 (Suppl. 10):S83-S94.
15. Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 1984;81:1575-9.
16. 2) in rat brain. Am J Physiol 1991;261:R209-R216.
17. Tsutsumi K, Saavedra JM. Increased dithiothreitol-insensitive, type 2 angiotensin II receptors in selected brain areas of young rat. Cell Mol Neurobiol 1991;11:295-9.
18. Tsutsumi K, Saavedra JM. Quantitative autoradiography reveals different Angiotensin II receptor subtypes in selected rat brain nuclei. J Neurochem 1991;56:348-51.
19. Tsutsumi K, Saavedra JM. Differential development of angiotensin II receptor subtypes in the rat brain. Endocrinol 1991;128:630-2.
20. Shigematsu K, Saavedra JM, Plunkett LM, Kurihara M, Correa FMA. Angiotensin II binding sites in the anteroventral-third ventricle (AV3V) area and related structures of the rat brain. Neurosci Lett 1986; 67:37-41.
21. 2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol 1991;261:H667-H670.
22. 1 blockade normalises cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000; 31:2478-86.
23. Brecher P, Tercyak A, Chobanian AV. Properties of angiotensin-converting enzyme in intact cerebral micro vessels. Hypertension 1981;3:198-204.
24. Perich R, Jackson B, Paxton D, Johnston C. Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats. J Hypertens 1992;10:149-53.
25. Speth RC, Harik SI. Angiotensin II receptor binding sites in brain microvessels. Proc Natl Acad Sci USA 1985;82:6340-3.
26. Saavedra JM, Nishimura Y. Angiotensin and cerebral blood flow. Cell Molec Neurobiol 1999;19:553-73.
27. 1, receptor mediated contraction of the perfused rat cerebral artery. NeuroReport 1994;5:2278-80.
28. Barry DI, Jarden JO, Paulson OB, Graham DI, Strandgaard S. Cerebrovascular aspects of converting-enzyme inhibition. 1: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. J Hypertens 1984;2:589-97.
29. Postiglione A, Bobkiewicz T, Vinholdt-Pedersen E, Lassen N, Paulson OB, Barry DI. Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats. Stroke 1991;22:1363-8.
30. Paulson OB, Waldemar G. Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation. Blood Vessels 1991;28:231-5.
31. Bray L, Lartaud I, Muller F, Atkinson J, Capdeville C. Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats. Am J Hypertens 1991;4:246S-252S.
32. Torup M, Waldemar G, Paulson OB. Ceranapril and cerebral blood flow autoregulation. J Hypertens 1993;1:399-405.
33. Frei A, Muller-Brand J. Cerebral blood flow and antihypertensive treatment with enalapril. J Hypertens 1986;4:365-7.
34. Waldemar G, Ibsen H, Strandgaard S, Andersen AR, Reasmissen S, Paulson OB. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension. Am J Hypertens 1990;13:464-70.
35. Toyoda K, Fujii K, Ibayashi S et al. Attenuation and recovery of brain stem autoregulation in spontaneously hypertensive rats. J Cereb Blood Flow Metab 1998;18:305-10.
36. Hajdu MA, Heistad DD, Ghoncim S, Baumbach GE. Effects of antihypertensive treatment on composition of cerebral arterioles. Hypertension 1991;18 (Suppl. 11):1115-21.
37. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effects of antihypertensive treatment on focal cerebral infarction. Hypertension 1992;19:713-6.
38. Sadoshima S, Nagao T, Ibayashi S, Fujishima M. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats. Hypertension 1994;23:781-5.
39. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral isclemia in rats. Stroke 1991;22:910-14.
40. Veniant M, Clozel JP, Kuhn P, Clozel M. Protective effect of cilazapril on the cerebral circulation. J Cardiovasc Pharmacol 1992;19 (Suppl. 6):S94-S99.
41. Moreau P, Takase H, Kung CF, van Rooijen MM, Schaffner T, Luscher TF. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke 1995;26:1922-8.
42. Nag S, Kilty DW. Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke 1997;28:1028-34.
43. Naritomi H, Shimizu T, Watanabe Y, Murata S, Sawada T. Effects of the Angiotensin converting enzyme inhibitor alacepril on cerebral blood flow in hypertensive stroke patients: A pilot study. Curr Ther Res 1994;55:1446-54.
44. Dyker AG, Grosset DG, Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580-3.
45. 2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: Agonist effects of CGP 42112 and PD 123319. J Cereb Blood Flow Metab 1994;14:38-44.
46. 2 receptors regulate CBF in rats. Neuroreport 1992;3:703-4.
47. Inada Y, Wada T, Ojima M et al. Protective effects of Candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke prone spontaneously hypertensive rats. Clin Expr Hypertens 1997;19:1079-99.
48. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharm 1993;22:305-13.
49. Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K. Role of angiotensin II in cerebrovascular and renal damage in deoxyorticosterone acetate-salt hypertensive rats. J Hypertens 1995;13:113-22.
50. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol 1988;255:H646-H650.
51. Vraamak T, Waldemar G, Strandgaard S, Paulson S. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens 1995;13:755-61.
52. 1, receptor expression. Basic Res Cardiol 1998; 93: (Suppl 2):63-8.
53. 125I]-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Meth 1989;30:247-53.
54. Dirnagl U, Kaplan B, Jacewicz M, Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab 1989;9:589-96.
55. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
56. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304-8.
57. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp RF. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10:290-5.
58. 1-receptors. Brain Res 2000; 871:29-38.
59. Liu Y, Mituska S, Hashizuma K, Hosaka T, Nukui H. The sequential change of local CBF and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effects of MK-801 on local cerebral glucose metabolism. Acta Neurochir (Wien) 1997;139:770-79.
60. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke 1991;22:910-14.
61. 1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999; 30:2391-9.
62. Nobile-Orazio E, Sterzi R. Cerebral ischemia after nifedipine treatment. Br Med J (Clin Res Ed) 1981;283:948.
63. Blezer ELA, Klaas N, Bar D et al. Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats. Stroke 1998;29:1671-8.
64. Griendling KK, Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997;7:301-7.
65. Pueyo ME, Arnal J-F, Rami J, Michel J-D. Angiotensin stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998;274:C214-C220.
66. 2 radicals in arachidonate-induced increased blood brain barrier permeability to proteins. Am J Physiol 1986;251:H693-H699.
67. Lees KR, Dyker AG. BP control after acute stroke. J Hypertens Suppl 1996;14:S35-S38.
68. Paxinos G, Watson Ch. The rat brain in stereotaxic coordinates. NewYork: Academic Press, 1986:1-118.